PMA P950034S001

Device
SEPRAFILM(TM) (HAL-F(TM)) BIORESORBABLE MEMBRANE
Applicant
Baxter Healthcare Corporation
PMA number
P950034
Supplement
S001
Product code
MCN
Decision date
1996-11-07
Generic name
Barrier, absorbable, adhesion
Approval order statement
CHANGE IN THE CURRENT HA/CMC SPECIFICATION FOR THE UREA ASSAY FROM THE CURRENT 3 - 15% TO A SPECIFICATION OF 10-18% FOR THE MODIFIED ASSAY. THE SUPPLEMENT ALSO REQUESTS THE REPLACEMENT OF THE USP RABBIT PYROGEN ASSAY WITH THE LIMULUS AMOEBOCYTE LYSATE (LAL) ASSAY AS THE STANDARD PYROGEN TEST

Current openFDA PMA Record#

Device
SEPRAFILM(TM) (HAL-F(TM)) BIORESORBABLE MEMBRANE
Applicant
Baxter Healthcare Corporation
PMA number
P950034
Supplement
S001
Product code
MCN
Generic name
Barrier, absorbable, adhesion
Decision date
1996-11-07
Decision code
APPR
Date received
1996-10-22
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
CHANGE IN THE CURRENT HA/CMC SPECIFICATION FOR THE UREA ASSAY FROM THE CURRENT 3 - 15% TO A SPECIFICATION OF 10-18% FOR THE MODIFIED ASSAY. THE SUPPLEMENT ALSO REQUESTS THE REPLACEMENT OF THE USP RABBIT PYROGEN ASSAY WITH THE LIMULUS AMOEBOCYTE LYSATE (LAL) ASSAY AS THE STANDARD PYROGEN TEST